Ecron Acunova-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ecron Acunova - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013182
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clinical trials, peri approval studies, PMS, rescue studies, clinical data management and biostatistics, medical writing, regulatory affairs, pharmacovigilance, and central laboratory. Ecron provides bioavailability and bioequivalence services such as consulting, IP import and sample export, protocol design, ethics committee submissions, safety screening and bio analytical testing. The company serves pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. It operates in South East Asia, Central and Nordic Europe and North America. Ecron Acunova is headquartered in Bangalore, Karnataka, India.

Ecron Acunova – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ecron Acunova, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Partnerships 12
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
Acquisition 13
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova – Key Competitors 15
Ecron Acunova – Key Employees 16
Ecron Acunova – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Recent Developments 19
Other Significant Developments 19
Jun 09, 2017: Ecron Acunova to offer end-to-end capabilities as ‘Navitas Life Sciences 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ecron Acunova, Pharmaceuticals & Healthcare, Key Facts 2
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova, Key Competitors 15
Ecron Acunova, Key Employees 16
Ecron Acunova, Other Locations 17
Ecron Acunova, Subsidiaries 17
Ecron Acunova, Joint Venture 18

★海外企業調査レポート[Ecron Acunova-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Labrador Iron Mines Holdings Limited:企業の戦略・SWOT・財務分析
    Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Gazprom Marketing & Trading Ltd:企業の戦略的SWOT分析
    Gazprom Marketing & Trading Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Korea South-East Power Co Ltd:企業の戦略的SWOT分析
    Korea South-East Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • HDFC Standard Life Insurance Company Limited:企業のM&A・事業提携・投資動向
    HDFC Standard Life Insurance Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Standard Life Insurance Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • BioElectron Technology Corp-製薬・医療分野:企業M&A・提携分析
    Summary BioElectron Technology Corp(BioElectron) formerly known as Edison Pharmaceuticals Inc, discovers and develops shared (redox) disease drugs. The company’s pipeline products comprise EPI-743, a drug candidate for inherited mitochondrial diseases and EPI-589 drug candidate entering phase 1 clin …
  • PT. Bank Negara Indonesia (Persero) Tbk.:戦略・SWOT・企業財務分析
    PT. Bank Negara Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Negara Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • PAREXEL International Corporation:企業の戦略・SWOT・財務情報
    PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report Summary PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Security Networks AG:企業の戦略・SWOT・財務情報
    Security Networks AG - Strategy, SWOT and Corporate Finance Report Summary Security Networks AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bourbon SA (GBB):企業の戦略的SWOT分析
    Bourbon SA (GBB) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Viscom AG (V6C):企業の財務・戦略的SWOT分析
    Viscom AG (V6C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Marathon Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Marathon Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Marathon Oil Corp (MRO) is independent energy company, which explores, produces and markets liquid hydrocarbons and natural gas. It focuses mainly on unconventional resource plays in the US with op …
  • Genor BioPharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genor BioPharma Co Ltd (Genor) a subsidiary of Walvax Biotechnology Co Ltd is a bio-pharmaceutical company which develops and commercializes therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Its service offerings include process and assay deve …
  • University of California San Diego-医療機器分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Crown Bioscience Inc:企業のM&A・事業提携・投資動向
    Crown Bioscience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Crown Bioscience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ernst & Young Global Ltd
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Hunt’s Foodservice Ltd:企業の戦略・SWOT・財務情報
    Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report Summary Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CEVA Holdings LLC:戦略・SWOT・企業財務分析
    CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆